Reddit Posts
CHRS: 14% short interest on a highly promising small cap
CHRS: a highly promising biotech poised to break out
CHRS: a promising biotech poised to break out
CHRS: Notes from today's JP Morgan Health Care Conference presentation
CHRS to the moon baby! My tits are jacked!
$CHRS received FDA approval yesterday: ) Currently on sale, buying the dip!
Coherus will be up big today due to FDA approval—$CHRS
CHRS: A heavily shorted biotech with major catalysts upcoming
CHRS: A heavily shorted biotech with major catalysts upcoming
#premarket 08/19 $SONN - S1 sec reports, $SLRX - no news, $ESGC - The Huge Amazon Deal Leaving Eros STX Global Starstruck. $CHRS - Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01.. Any trading ideas? Welcome!
Coherus Bioscienes ($CHRS) is finally killing it, here’s why you should care.
A casualty GEM among the Biotech selloff
A Hidden GEM that has been a casualty of the recent Biotech Breakdown
Mentions
CHRS slow and steady to $2. No violent pumps and dumps.
I'm still bullish on CHRS. It will not be an overnight money maker, but worth a mid-term hold.
CHRS been mentioning this for a few weeks. Steady increase due to improved finances and development.
Though it gets few mentions, I've spoken about CHRS. Like most things, it took a huge beating on Friday. I held. I would still encourage people to monitor it Monday, pre-market, to see what is doing. I feel many will, again, see the value and buy in at this lower price, returning it to the multiple variable that can make it rise. I also held GERN and RVPH.
CHRS is something to watch as it's ripe for squeeze. Worth looking into.
CHRS is worth a DD as it pertains to short price and days coverage.
CHRS is still one to watch. It's had a steady rise and its short price is 1.64 with a 20 day coverage.
CHRS: Coherus Oncology. Stock have been rising due to positive financial and strategic developments, including a successful transition to a pure-play oncology company and the monetization of older assets. These moves have strengthened the company's financial position and built momentum for its cancer therapy pipeline. Lastly Analyst upgrades to a buy.
CHRS: Coherus Oncology. Stock have been rising due to positive financial and strategic developments, including a successful transition to a pure-play oncology company and the monetization of older assets. These moves have strengthened the company's financial position and built momentum for its cancer therapy pipeline. Lastly Analyst upgrades to a buy.
I've been on CHRS this week. A gradual rise. If it continues, as such, the squeeze could follow. High float, long to cover.
CHRS has been on a steady tear and will hit $2 soon
I'm on on GERN and CHRS for long
I'm in on GERN and CHRS.
CHRS has been on a tear
I will be watching CHRS this week.
IXHL, BTAI, and MBOT were huge for me. CHRS was a bust for strategic and financial reasons: an expected short squeeze never materialised because the company used huge cash inflows to pay down debts instead of contributing to an EPS spike. FBIO was almost a bag but their FDA rejection letter was because of non-drug-related issues, so averaging down paid off (for once).
It's a huge EPS boost unless they immediately spend the money. I thought I was in on an EPS-driven short squeeze with CHRS, but the company used the money to pay off debts.
Anyone have guesses on why CHRS is up so much today/recently?
What made CHRS go up this much? Are we anticipating something?
CHRS Coherus Oncology - finally found double bottom, now a little setback but still on track on its upward trend. They have promising results in their oncology drugs. The next catalysts are said to be in 2026/2027. Many potential drug combinations with other drug manufacturers are tested and show good results, which means their drugs are widely applicable. The company has more cash than market cap from recently selling one of their drugs to allow for manufacture in bigger quantities. More milestone payments will be coming in 2026. Acquisition rumors.
Just in case anyone is following me- nothing interesting here for me. I still have: CHRS, ANAB, NUVB, AUTL,HRTX, SPRY, PHAT. Will buy back BEAM, it was a mistake to sell it.
CHRS looking juicy bruh. Short interest is high too no cap
Anyone know what happened with CHRS? Up quite a lot today
I look at stocks PT too but often times I find that it’s incorrect. You can’t base it off only that. CHRS for example has it PT set at $4-$4.5 barely moves and not even close to it. With that said I’m in DVLT. Just not sure of the catalyst yet.
Keeping hear this alot😅 enter possible recession and low interest rates look at health care sector, gold miners My favorite is $CERS $CHRS both profitable and have $4 dollar price targets trading below$1.50 big upside to $3 over the next year with rates cuts...DD Good luck everyone
I'm in NUVB, ANAB,CHRS, SPRY,PHAT. Also HUMA and HRTX, but these 2 I don't recommend
CHRS ... the price sits at the company's cash pile. Check out the subreddit /chrs for extensive insight and help us get rid of the shorties!!! I invested around $3200 in the past 15 months with an average share price of $0.9
CHRS rocket has ignited once again. The price sits at the company's cash pile. Check out the subreddit /chrs and help us get rid of the shorties!!!
I forgot to mention that now I'm in NUVB, ANAB, HRTX, HUMA, CHRS, STOK SPRY, PHAT and plan to enter BEAM
There's nothing interesting for me. Just still holding my bag full of : ANAB, CHRS, STOK, NUVB, HUMA (maybe I'll throw it away soon) and HRTX
CHRS hovering around $1 right now with a price target of $4-$6
CHRS is the next OPEN
CHRS will run once it’s at $1 Last earnings a few days ago were promising
CHRS will run once it’s above $1
I'm just disapointed that I always arrive when the stock had a +1239819302814% upside, its like I always miss the big chances lol, happened to me with IXHL, CHRS, CTM, BTAI...
PHGE at the dip. I'm considering selling CHRS for it.
CHRS earnings are good. Not immediate squeeze fuel, as they spent most UDENYCA divestiture to pay down debts (meaning no spike in earnings-per-share), but revenue increased and they have a cash runway into 2026.
Anyone excited for CHRS earnings?
I'll sell it soon. Just keeping cash in a hype train until either MBOT, CHRS, or BTAI drop.
I wanted to put BTAI profits into either CHRS or MBOT, but neither is doing particularly badly.
CHRS? hold or sell Hmmmm.....?
My plays for the early morning! GORO/ NCNA/USIO/CHRS and PHGE. Please God let’s have an amazing pre- market with these guys!!! I want to wake up to a plus 1k.
Check out the CHRS subreddit, some sharp folks analyzing what upcoming ec could hold
All green. Eyeballing CHRS as a place to park CURI and BTAI profits.
What’s going on with CHRS??
Taking profits now to buy whichever of my heavy-hitters (BTAI, MBOT, and CHRS) dips the most tomorrow. Also waiting on CURI earnings after-market. If they're good, profits will go towards RZLV later in the month.
CHRS will report Aug 7th estimated to miss or have neg financials?
Mostly 5-20% up today. Just waiting on MBOT and CHRS to do their thing and TMC to bottom out.
Trying to trade up this week. Opening with CuriosityStream (CURI) and Gibo (GIBO), both for quick sale on the 5th after / ahead of earnings. Profits will be parked in Amprius Technologies (AMPX), to sell good earnings news on the 7th. Coherus (CHRS) is also likely to leap this week. Amprius and Coherus gains can be wheeled into Resolve AI (RZLV) for the end of the month, or held back depending what the weekend brings.
NVNI going crazy :) CHRS setting up for tomorrow
CHRS has good catalysts plus short potential in the next two weeks; CRDF is grossly undervalued; MBOT is expecting a positive FDA decision between now and Sep. 30th with amazing squeeze potential.
CHRS is anticipated to release their earnings next wek
CHRS starting to curl up
What’s next after IXHL? Hoping it’ll get back up to .80 so I can get out and pick up something else. Here’s what I’m thinking based on past performance, volume, current valuation, and trajectory: CTM CHRS NCNA UAVS KULR Thoughts?
Holding CHRS, SLS, and MBOT, but otherwise in T-bills this month. Something's spooky in small-cap markets; pennies are being starved of volume.
CHRS? Isn't it August 14th? How good is your performance?
CHRS could be big with their earnings call. Loaded up 7k shares
NVNI going to $2+ next week CHRS going to be $3+ after the earnings call this coming week (NFA)
VVPR & CHRS have a Friday eve everyone 😁
VVPR and CHRS slow and steady with upcoming earnings / recent news 😎
For those who aren’t pumping and dumping, CHRS
I'm less certain than I was (volume spooked), but CHRS is still a potential squeeze tomorrow. Not 200%+, but a decent shot in uncertain times.
I wish I had some free money to add to positions — I am holding RR and CTM longer term. I am holding CHRS short term I want to get into UGRO and BBAI at these price points for longer term
CHRS. A massive earnings-per-share boost is due on the 31st, and, with sufficient volume, could catch its huge short float asleep at the wheel. Today makes the risk and reward higher as the price dips back under a dollar; that sparks algorithmic shorting.
CHRS will be where I roll my profits after IXHL, NVNI and ADIL.
Still in NVNI and CHRS for the week, and MBOT for the month. Hopefully small-cap outflows calm down today; Trump's tariff merry-go-round is old news.
CHRS and MBOT are my squeeze plays for this week / month (or until whenever MBOT gets federal approval).
I'm trying to buy CHRS after hours and it's not going through. Is it not traded after hours?
CHRS is forming a bullish Williams %R pattern. and traders are starting to notice! According to Trading Central, CHRS has triggered a bullish Williams %R signal after breaking out from the oversold zone (crossing above -80), now trending up and potentially heading for a new short-term rally. **Why is this important?** The Williams %R is a momentum oscillator that helps detect reversals. It works by comparing the current closing price to the high-low range over the last 14 periods. * When %R moves above -80, it suggests a recovery from oversold conditions. * If it keeps rising through -50, it often confirms that a new bullish trend is forming. In simple terms: * It’s not just a bounce, but a potential trend reversal signal. * Combined with CHRS’s tight float, strong institutional ownership, and biotech catalysts, this could bring serious short-term momentum. Keep your eyes on this one. **CHRS may just be getting started**.
They were trimming their positions because CHRS had dropped below $1.00. and when that happens, institutions usually reduce their holdings in case the stock fails to regain compliance and risks getting delisted. But now that it’s stayed above $1.00 for three straight days, if it keeps that up for 10 days, they’ll start coming back in. That’s when it can explode. and yeah, we’re already on day 3 above $1.00. They know the potential here. That’s why this is the time to buy and take a shot at some real gains. But hey, if it doesn’t sit right with you, then don’t do it. just watch the profits roll by. This game’s all about risk and reward. The one who dares wins, the one who doesn’t just watches. Just don’t go all in. be smart with your portfolio.
Followed your advice about CHRS and it's working well (Please have good ER next week). Gonna give FF a try again. in at 300 shares @ 4.18
I wouldn't buy into this. According to quiver quantitative, at least 51 institutions reduced their holdings with CHRS. If it's true, this makes me scared about buying CHRS. https://www.quiverquant.com/news/%24CHRS+stock+is+up+8%25+today.+Here%27s+what+we+see+in+our+data.
CHRS might be entering early accumulation. While we’re not seeing consistent volume spikes above 1M shares daily, there are early signs worth watching: the bullish shift in Williams %R, a relatively tight float, and a strong fundamental pivot to pure oncology. That said, we should be cautious calling this “real accumulation” just yet. True smart money positioning is typically accompanied by repeated volume surges. and that hasn’t clearly materialized over the past 30 trading days. Bottom line**:** CHRS is showing signs of early interest**,** but we need confirmation through volume and a clean technical breakout. Still, the setup is one to watch closely. fundamentals are lining up, and the float makes this one move fast when it’s ready.
CHRS showing real signs of accumulation here, tight float, bullish %R shift, and biotech upside make this more than just a technical blip. Smart money might already be positioning.
I am rocking $CHRS short term. Overexposed short with earning catalyst
CHRS and MBOT for that squeeze potential. Profits can go into NVNI or IXHL after the sell-off.